CM082, a novel angiogenesis inhibitor, enhances the antitumor activity of gefitinib on epidermal growth factor receptor mutant non-small cell lung cancer in vitro and in vivo. [PDF]
Background CM082 is a novel angiogenesis inhibitor targeting vascular endothelial growth factor receptor (VEGFR) and platelet‐derived growth factor receptor (PDGFR).
Zhang K, Wang L, Wei A, Jia X, Liu X.
europepmc +2 more sources
Phase 1/2a Study of Rivoceranib, a Selective VEGFR-2 Angiogenesis Inhibitor, in Patients with Advanced Solid Tumors. [PDF]
Kang YK +13 more
europepmc +1 more source
Angiogenesis Inhibitor Drug-induced Benign Migratory Glossitis in a Patient of Juvenile-onset Recurrent Respiratory Papillomatosis under Maintenance Therapy. [PDF]
Kalra N +4 more
europepmc +1 more source
First-line angiogenesis inhibitor plus erlotinib versus erlotinib alone for advanced non-small-cell lung cancer harboring an EGFR mutation. [PDF]
Landre T +5 more
europepmc +1 more source
A MgAl-LDH-CuS nanosheet-based thermo-responsive composite hydrogel with nir-responsive angiogenesis inhibitor releasing capability for multimode starvation therapy. [PDF]
Liu X +9 more
europepmc +1 more source
Pharmacology Study of the Multiple Angiogenesis Inhibitor RC28-E on Anti-Fibrosis in a Chemically Induced Lung Injury Model. [PDF]
Kou X +6 more
europepmc +1 more source
A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling. [PDF]
Huang Y +11 more
europepmc +1 more source
HIF-1α represses the expression of the angiogenesis inhibitor thrombospondin-2. [PDF]
MacLauchlan SC +9 more
europepmc +1 more source
Neoadjuvant Therapy of Cervical Carcinoma with the Angiogenesis Inhibitor Bevacizumab: a Single-Centre Analysis. [PDF]
Junker P +9 more
europepmc +1 more source

